BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UM//UM*Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Detroit
TZURL:http://tzurl.org/zoneinfo/America/Detroit
X-LIC-LOCATION:America/Detroit
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20070311T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20071104T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20231107T082434
DTSTART;TZID=America/Detroit:20231114T160000
DTEND;TZID=America/Detroit:20231114T171500
SUMMARY:Workshop / Seminar:Leveraging Metalloenzymes for Human Health and Disease
DESCRIPTION:Pathogens of all kinds continue to represent major public health challenges and demand new therapeutic strategies. Our lab focuses on developing therapeutics that derive from mechanistic analysis of anaerobic enzymes. Two of our projects are based on the iron-sulfur cluster enzymes Viperin and MqnE.  Viperin\, an acronym derived from the enzymes conspicuous properties (virus-inhibitory protein\, endoplasmic reticulum-associated\, interferon inducible)\, is an interferon inducible protein found in all higher eukaryotes that inhibits the replication of a remarkable range of both RNA and DNA viruses. We recently discovered that viperin converts the ribonucleotide CTP to a novel compound 3ʹ-deoxy-3′\,4ʹ-didehydro-CTP (ddhCTP) through a radical-based mechanism. Interestingly\, bacterial\, fungal\, and archaeal viperin-like enzymes are divergent in substrate specificity\, producing alternative ddh-nucleotide triphosphate (ddhNTP) products (i.e. ddhUTP\, ddhGTP). Our recent studies understanding the mechanism by which viperin and viperin-like enzymes catalyze this reaction and the structural basis for their divergent nucleotide specificity will be the focus of Part 1 of my talk. Part 2 will focus on the enzyme MqnE from Helicobacter pylori\, which is involved in menaquinone (MK) biosynthesis. MK is a soluble lipid cofactor needed for the respiratory chain in all anaerobic bacteria.  MK can be synthesized by two pathways: the canonical pathway and the futalosine pathway. Fortunately\, the futalosine pathway is only found in a narrow set of bacteria—including Helicobacter pylori—which are not normally found in the human digestive track\, making this pathway an attractive target for the development of narrow spectrum antibiotics. Our research has focused on understanding the catalytic mechanism of this central enzyme and development of inhibitors against it\, employing a combination of traditional enzymology\, structural biology\, and drug discovery.
UID:109264-21821325@events.umich.edu
URL:https://events.umich.edu/event/109264
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Chemical Biology,Chemistry,Science
LOCATION:Chemistry Dow Lab - 1640
CONTACT:
END:VEVENT
END:VCALENDAR